Join to View Full Profile
14200 W. Celebrate Life Way.Goodyear, AZ 85338
Phone+1 602-883-1259
Dr. Bryce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2006 - 2009- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003, MD
UCLABS, Biochemistry , 1994 - 1998
Certifications & Licensure
CA State Medical License 2009 - Present
UT State Medical License 2025 - 2028
AZ State Medical License 2011 - 2027
CO State Medical License 2025 - 2027
NV State Medical License 2025 - 2027
NM State Medical License 2025 - 2026
MN State Medical License 2004 - 2009
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab Start of enrollment: 2018 Apr 24
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
- Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 Start of enrollment: 2020 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsSystemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Update.Rohan Garje, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, R Bryan Rumble, Mary-Ellen Taplin
Journal of Clinical Oncology. 2025-07-10 - Thromboembolic Events in Castration-Resistant Prostate Cancer Patients With and Without Cardiovascular Comorbidities Receiving Oral Androgen Receptor Pathway Inhibitors.Ibrahim M Asiri, Ronald C Chen, Viraj Master, Lanyu Mi, Sarah E James
The Prostate. 2025-07-01 - 2 citationsRecent and Future Developments in the Use of Poly (ADP-ribose) Polymerase Inhibitors for Prostate Cancer.Francesca Zacchi, Wassim Abida, Emmanuel S Antonarakis, Alan H Bryce, Elena Castro
European Urology Oncology. 2025-06-01
Journal Articles
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer SyndromeScott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology
Lectures
- Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Clinical Hematology and Oncology 2013: The 10th Annual Mayo Board ReviewMayo School of Continuous Professional Development, Scottsdale, Arizona - 1/18/2013
Press Mentions
Insights from ASCO 2025: Real-World Evidence Drives Clinical Decision-MakingJune 13th, 2025
City of Hope Researchers to Unveil Promising Cancer Advances Aiming to Improve Survival at ASCO Annual MeetingMay 22nd, 2025- Why Biden May Not Have Known About His 'Aggressive' Prostate Cancer Until RecentlyMay 19th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
